ABCL
Price
$4.12
Change
-$0.17 (-3.96%)
Updated
Jan 15, 11:07 AM (EDT)
Capitalization
1.29B
40 days until earnings call
Intraday BUY SELL Signals
LCTX
Price
$1.67
Change
-$0.03 (-1.76%)
Updated
Jan 15, 11:46 AM (EDT)
Capitalization
391.56M
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs LCTX

Header iconABCL vs LCTX Comparison
Open Charts ABCL vs LCTXBanner chart's image
AbCellera Biologics
Price$4.12
Change-$0.17 (-3.96%)
Volume$2.3K
Capitalization1.29B
Lineage Cell Therapeutics
Price$1.67
Change-$0.03 (-1.76%)
Volume$300
Capitalization391.56M
ABCL vs LCTX Comparison Chart in %
View a ticker or compare two or three
VS
ABCL vs. LCTX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and LCTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (ABCL: $4.29 vs. LCTX: $1.70)
Brand notoriety: ABCL and LCTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 99% vs. LCTX: 49%
Market capitalization -- ABCL: $1.29B vs. LCTX: $391.56M
ABCL [@Biotechnology] is valued at $1.29B. LCTX’s [@Biotechnology] market capitalization is $391.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileLCTX’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • LCTX’s FA Score: 0 green, 5 red.
According to our system of comparison, LCTX is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while LCTX’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 6 bearish.
  • LCTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LCTX is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а +3.87% price change this week, while LCTX (@Biotechnology) price change was -7.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

ABCL is expected to report earnings on Feb 24, 2026.

LCTX is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.29B) has a higher market cap than LCTX($392M). ABCL YTD gains are higher at: 25.439 vs. LCTX (1.796). LCTX has higher annual earnings (EBITDA): -19.68M vs. ABCL (-212.36M). ABCL has more cash in the bank: 496M vs. LCTX (40.5M). LCTX has less debt than ABCL: LCTX (2.62M) vs ABCL (142M). ABCL has higher revenues than LCTX: ABCL (35.3M) vs LCTX (10.8M).
ABCLLCTXABCL / LCTX
Capitalization1.29B392M328%
EBITDA-212.36M-19.68M1,079%
Gain YTD25.4391.7961,416%
P/E RatioN/AN/A-
Revenue35.3M10.8M327%
Total Cash496M40.5M1,225%
Total Debt142M2.62M5,418%
FUNDAMENTALS RATINGS
LCTX: Fundamental Ratings
LCTX
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
62
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLLCTX
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
Bearish Trend 16 days ago
85%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signal:
Gain/Loss:
LCTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PVFIX16.570.09
+0.55%
Pinnacle Value
ODVNX34.250.14
+0.41%
Invesco Developing Markets R
WLCTX12.510.04
+0.32%
Wilshire International Equity Invmt
FSTRX35.66N/A
N/A
Federated Hermes MDT Large Cap Value A
BGAIX50.93-0.51
-0.99%
Baron Global Opportunity Institutional

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with ABSI. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then ABSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+0.47%
ABSI - ABCL
59%
Loosely correlated
+1.21%
RXRX - ABCL
58%
Loosely correlated
+3.41%
CRSP - ABCL
56%
Loosely correlated
+1.26%
VCYT - ABCL
56%
Loosely correlated
-1.39%
DNA - ABCL
51%
Loosely correlated
+2.39%
More

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
+1.80%
MDGL - LCTX
43%
Loosely correlated
+2.29%
ABCL - LCTX
39%
Loosely correlated
+0.47%
CRSP - LCTX
37%
Loosely correlated
+1.26%
RXRX - LCTX
36%
Loosely correlated
+3.41%
VIR - LCTX
36%
Loosely correlated
+8.08%
More